Authors:
TARTOUR E
GEY A
SASTREGARAU X
SURIN IL
MOSSERI V
FRIDMAN WH
Citation: E. Tartour et al., PROGNOSTIC VALUE OF INTRATUMORAL INTERFERON-GAMMA MESSENGER-RNA EXPRESSION IN INVASIVE CERVICAL CARCINOMAS, Journal of the National Cancer Institute, 90(4), 1998, pp. 287-294
Authors:
CLOUGH KB
CUMINET J
FITOUSSI A
NOS C
MOSSERI V
Citation: Kb. Clough et al., COSMETIC SEQUELAE AFTER CONSERVATIVE TREATMENT FOR BREAST-CANCER - CLASSIFICATION AND RESULTS OF SURGICAL-CORRECTION, Annals of plastic surgery, 41(5), 1998, pp. 471-481
Authors:
PAGES F
FLAM TA
VIEILLEFOND A
MOLINIE V
ABEILLE X
LAZAR V
BRESSACDEPAILLERETS B
MOSSERI V
ZERBIB M
FRIDMAN WH
DEBRE B
THIOUNN N
Citation: F. Pages et al., P53 STATUS DOES NOT PREDICT INITIAL CLINICAL-RESPONSE TO BACILLUS-CALMETTE-GUERIN INTRAVESICAL THERAPY IN T1 BLADDER-TUMORS, The Journal of urology, 159(3), 1998, pp. 1079-1084
Authors:
MONTEROJULIAN FA
BRAILLY H
SAUTES C
JOYEUX I
DORVAL T
MOSSERI V
YASUKAWA K
WIJDENES J
ADLER A
GORIN I
FRIDMAN WH
TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
Authors:
REMVIKOS Y
MOSSERI V
ASSELAIN B
FOURQUET A
DURAND JC
POUILLART P
MAGDELENAT H
Citation: Y. Remvikos et al., S-PHASE FRACTIONS OF BREAST-CANCER PREDICT OVERALL AND POST-RELAPSE SURVIVAL, European journal of cancer, 33(4), 1997, pp. 581-586
Authors:
TIERNEY JF
STEWART LA
PARMAR MKB
FLETCHER CDM
JONES G
MOSSERI V
PATEL M
DEELVIRA MCR
SOUHAMI RL
SYLVESTER R
TURSZ T
ALVEGARD TA
SIGURDSSON H
ANTMAN K
BACCHI M
BAKER LH
BENJAMIN RS
BRADY MF
BRAMWELL V
BUI BN
EDMONSON JH
LEYVRAZ S
OMURA GA
ROUESSE J
RYAN L
VANOOSTEROM AT
YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
Authors:
TARTOUR E
DENEUX L
MOSSERI V
JAULERRY C
BRUNIN F
POINT D
VALIDIRE P
DUBRAY B
FRIDMAN WH
RODRIGUEZ J
Citation: E. Tartour et al., SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVEL AS A PREDICTOR OF LOCOREGIONAL CONTROL AND SURVIVAL FOR PATIENTS WITH HEAD AND NECK-CARCINOMA - RESULTS OF A MULTIVARIATE PROSPECTIVE-STUDY, Cancer, 79(7), 1997, pp. 1401-1408
Authors:
STOPPALYONNET D
LAURENTPUIG P
ESSIOUX L
PAGES S
ITHIER G
LIGOT L
FOURQUET A
SALMON RJ
CLOUGH KB
POUILLART P
ALAPETITE C
ALEPEE B
KLIJANIENKO J
ASSELAIN B
BEUZEBOC P
BOURGEOIS D
BOURGEOIS H
BOURSTYN E
BRUNIN F
CAMPANA F
CHAUVEINC F
COSSET JM
DECREMOUX P
DELAROCHEFORDIERE A
DELATTRE C
DEMARGERIE V
DESTGAUDENS AB
DIERAS V
DORVAL T
DUBRAY B
DURAND JC
FALCOU MC
FITOUSSI F
GARCIAGIRALT E
GIRAUD P
GAUTIER C
GUGLIELMINA JN
HAMELIN JP
HOFFMAN H
JAULERRY C
JOUVE M
LABETA C
LEGALL M
MAGDELENAT H
MEUNIER M
MOSSERI V
NGUYEN TT
NATALI JC
NEUENSCHWANDER S
NOS C
OLIVIER L
PALANGIE T
PIERGA JY
PONTVERT D
ROGE P
SASTREGAREAU X
SCHLIENGER P
SCHOLL S
SELINGER R
THIBAULT F
THIS P
TROPHILME D
VALIDIRE P
VIELH P
VILCOQ JR
VINCENTSALOMON A
VOILLEMOT N
ZAFRANI B
BONAITIPELLIE C
THOMAS G
Citation: D. Stoppalyonnet et al., BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/, American journal of human genetics, 60(5), 1997, pp. 1021-1030
Authors:
DOZ F
PETER M
SCHLEIERMACHER G
VIELH P
VALIDIRE P
PUTTERMAN M
BLANQUET V
DESJARDINS L
DUFIER JL
ZUCKER JM
MOSSERI V
THOMAS G
MAGDELENAT H
DELATTRE O
Citation: F. Doz et al., N-MYC AMPLIFICATION LOSS OF HETEROZYGOSITY ON THE SHORT ARM OF CHROMOSOME-I AND DNA-PLOIDY IN RETINOBLASTOMA, European journal of cancer, 32A(4), 1996, pp. 645-649
Authors:
TARTOUR E
BLAY JY
DORVAL T
ESCUDIER B
MOSSERI V
DOUILLARD JY
DENEUX L
GORIN I
NEGRIER S
MATHIOT C
POUILLART P
FRIDMAN WH
Citation: E. Tartour et al., PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1697-1703
Authors:
JAULERRY C
DUBRAY B
MOSSERI V
BRUNIN F
RODRIGUEZ J
POINT D
BLASZKA B
ASSELAIN B
BRUGERE J
COSSET JM
Citation: C. Jaulerry et al., PROGNOSTIC VALUE OF TUMOR-REGRESSION DURING RADIOTHERAPY OR CHEMORADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCERS - REGARDING JAULERRY ET-ALIJROBP 33(2) 271-279 - 1995 - REPLY/, International journal of radiation oncology, biology, physics, 34(4), 1996, pp. 971-971
Authors:
SCHOLL SM
LIDEREAU R
DELAROCHEFORDIERE A
LENIR CCS
MOSSERI V
NOGUES C
POUILLART P
STANLEY ER
Citation: Sm. Scholl et al., CIRCULATING LEVELS OF THE MACROPHAGE-COLONY-STIMULATING FACTOR CSF-1 IN PRIMARY AND METASTATIC BREAST-CANCER PATIENTS - A PILOT-STUDY, Breast cancer research and treatment, 39(3), 1996, pp. 275-283
Authors:
PIERGA JY
LEROYER A
VIEHL P
MOSSERI V
CHEVILLARD S
MAGDELENAT H
Citation: Jy. Pierga et al., LONG-TERM PROGNOSTIC VALUE OF GROWTH FRACTION DETERMINATION BY KI-67 IMMUNOSTAINING IN PRIMARY OPERABLE BREAST-CANCER, Breast cancer research and treatment, 37(1), 1996, pp. 57-64
Authors:
DUBRAY B
MOSSERI V
BRUNIN F
JAULERRY C
PONCET P
RODRIGUEZ J
BRUGERE J
POINT D
GIRAUD P
COSSET JM
Citation: B. Dubray et al., ANEMIA IS ASSOCIATED WITH LOWER LOCAL-REGIONAL CONTROL AND SURVIVAL AFTER RADIATION-THERAPY FOR HEAD AND NECK-CANCER - A PROSPECTIVE-STUDY, Radiology, 201(2), 1996, pp. 553-558
Authors:
SCHLEIERMACHER G
DELATTRE O
PETER M
MOSSERI V
DELONLAY P
VIELH P
THOMAS G
ZUCKER JM
MAGDELENAT H
MICHON J
Citation: G. Schleiermacher et al., CLINICAL RELEVANCE OF LOSS OF HETEROZYGOSITY OF THE SHORT ARM OF CHROMOSOME-1 IN NEUROBLASTOMA - A SINGLE-INSTITUTION STUDY, International journal of cancer, 69(2), 1996, pp. 73-78
Authors:
SACCOMANDI E
CLOUGH KB
MOSSERI V
VIEHL P
LEGAL M
FOURQUET A
RENOLLEAU C
DURAND JC
Citation: E. Saccomandi et al., BREAST-CANCER REVEALED BY CLUSTER OF MICR OCALCIFICATIONS WITHOUT PALPABLE MASS - PROGNOSIS AND TREATMENT, La Presse medicale, 24(28), 1995, pp. 1291-1295
Authors:
BROET P
DELAROCHEFORDIERE A
SCHOLL SM
FOURQUET A
MOSSERI V
DURAND JC
POUILLART P
ASSELAIN B
Citation: P. Broet et al., CONTRALATERAL BREAST-CANCER - ANNUAL INCIDENCE AND RISK PARAMETERS, Journal of clinical oncology, 13(7), 1995, pp. 1578-1583
Authors:
DOZ F
NEUENSCHWANDER S
PLANTAZ D
COURBON B
GENTET JC
BOUFFET E
MOSSERI V
VANNIER JP
MECHINAUD F
DESJARDINS L
VIELH P
ZUCKER JM
Citation: F. Doz et al., ETOPOSIDE AND CARBOPLATIN IN EXTRAOCULAR RETINOBLASTOMA - A STUDY BY THE SOCIETE-FRANCAISE-DONCOLOGIE-PEDIATRIQUE, Journal of clinical oncology, 13(4), 1995, pp. 902-909
Authors:
JAULERRY C
DUBRAY B
BRUNIN F
RODRIGUEZ J
POINT D
BLASZKA B
ASSELAIN B
MOSSERI V
BRUGERE J
COSSET JM
Citation: C. Jaulerry et al., PROGNOSTIC VALUE OF TUMOR-REGRESSION DURING RADIOTHERAPY FOR HEAD ANDNECK-CANCER - A PROSPECTIVE-STUDY, International journal of radiation oncology, biology, physics, 33(2), 1995, pp. 271-279
Authors:
MAHER M
CAMPANA F
MOSSERI V
DREYFUS H
VILCOQ JR
GAUTIER C
ASSELAIN B
FOURQUET A
Citation: M. Maher et al., BREAST-CANCER IN ELDERLY WOMEN - A RETROSPECTIVE ANALYSIS OF COMBINEDTREATMENT WITH TAMOXIFEN AND ONCE-WEEKLY IRRADIATION, International journal of radiation oncology, biology, physics, 31(4), 1995, pp. 783-789
Authors:
FOURQUET A
CAMPANA F
MOSSERI V
CETINGOZ R
LUCIANI S
LABIB A
ASSELAIN B
VILCOQ JR
Citation: A. Fourquet et al., IR-192 VERSUS CO-60 BOOST IN 3-7 CM BREAST-CANCER TREATED BY IRRADIATION ALONE - FINAL RESULTS OF A RANDOMIZED TRIAL (VOL 34, PG 114, 1995), Radiotherapy and oncology, 35(2), 1995, pp. 169-169
Authors:
FOURQUET A
CAMPANA F
MOSSERI V
CETINGOZ R
LUCIANI S
LABIB A
ASSELAIN B
VILCOQ JR
Citation: A. Fourquet et al., IR-192 VERSUS CO-60 BOOST IN 3-7-CM BREAST-CANCER TREATED BY IRRADIATION ALONE - FINAL RESULTS OF A RANDOMIZED TRIAL, Radiotherapy and oncology, 34(2), 1995, pp. 114-120
Authors:
DUBRAY BM
MOSSERI V
BRUNIN F
JAULERRY C
PONCET P
RODRIGUEZ J
Citation: Bm. Dubray et al., ANEMIA ASSOCIATED WITH LOWER LOCAL-REGIONAL CONTROL AND SURVIVAL PROBABILITIES AFTER RADIATION-THERAPY FOR HEAD AND NECK-CANCER - PROSPECTIVE-STUDY, Radiology, 197, 1995, pp. 224-224